newsfilter
← Latest News
GlobeNewswire·

BioNTech Announces Full Year 2019 Financial Results and Corporate Update

BNT111 FixVac Melanoma registrational trial start planned for 2H 2020 BNT121 (iNeST) adjuvant Phase 2 study in NSCLC to start in 2H 2020COVID-19 vaccine program BNT162 set to enter the clinic in April...